This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Consensus papers

EAS Consensus Position Paper Initiative

Since 2009, the European Atherosclerosis Society has brought together internationally renowned experts in specific key aspects of atherosclerosis and cardiovascular disease, to publish a series of consensus publications addressing topical issues of major relevance to our membership and the scientific community. The Consensus Panel is co-chaired by Professors John Chapman, Henry Ginsberg and Alberico Catapano. The Papers have been published in high-impact journals and are widely cited.

Low-density lipoproteins cause atheroscleroticcardiovascular disease: pathophysiological, genetic, and therapeutic insights :: Quantifying Atherogenic Lipoproteins (2020) :: Adverse effects of statins :: Familial Hypercholesterolaemia in Children and Adolescents :: Statin-associated muscle symptoms (SAMS) :: Homozygous familial hypercholesterolaemia :: The polygenic nature of hypertriglyceridaemia :: Plant sterols and plant stanols :: Familial hypercholesterolaemia is underdiagnosed and undertreated :: Triglyceride-rich lipoproteins :: Lipoprotein(a) as a cardiovascular risk factor :: ESC/EAS on PCSK9 :: LDL causes ASCVD :: Update of ESC/EAS Task Force on practical clinical guidance on PCSK9 :: Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points. A joint consensus statement from the EAS and EFLM

Membership Software Powered by YourMembership  ::  Legal